home / stock / hrow / hrow news


HROW News and Press, Harrow Health Inc. From 03/02/26

Stock Information

Company Name: Harrow Health Inc.
Stock Symbol: HROW
Market: NASDAQ
Website: harrowinc.com

Menu

HROW HROW Quote HROW Short HROW News HROW Articles HROW Message Board
Get HROW Alerts

News, Short Squeeze, Breakout and More Instantly...

HROW - Harrow Announces Q4 and Full-Year 2025 Financial Results and 2026 Financial Guidance

Fourth Quarter, Full-Year 2025 and Selected Highlights:  Record quarterly revenue of $89.1 million, a 33% increase over $66.8 million recorded in the prior-year period Full-Year revenue of $272.3 million, a 36% increase over $199.6 million recorded in 2024 GAAP net income of $6.6 milli...

HROW - Expected US Company Earnings on Monday, March 2nd, 2026

Astrana Health Inc. (ASTH) is expected to report $0.15 for Q4 2025 Sealed Air Corporation (SEE) is expected to report $0.72 for Q4 2025 Surgery Partners Inc. (SGRY) is expected to report $0.27 for Q4 2025 Kuehne + Nagel International AG ADR (KHNGY) is expected to report $0.4 for Q4 20...

HROW - Harrow Health Q4 2025 Earnings Preview

2026-02-27 17:35:50 ET More on Harrow Health Harrow: Revisiting This Eyecare Growth Story Ahead Of Q4 Update Harrow: Flirting With Missing 2025 Revised Guidance Harrow: Vevye Replaces Xiidra On Tier 1 Formulary At CVS Seeking Alpha’s Quant Rating on Ha...

HROW - Harrow To Report Fourth Quarter and Year-End 2025 Financial Results After Market Close on March 2, 2026

NASHVILLE, Tenn., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it will report its financial results for the fourth quarter and year ended December 31, 2025, on Monday, March 2, 2026, a...

HROW - Harrow Announces Cash-Pay Direct-to-Prescriber PharmaPack(TM) Kits

NASHVILLE, Tenn., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the launch of a new Direct-to-Prescriber (DTP) cash-pay offering called PharmaPack, which expands the Company’s commitm...

HROW - Harrow Reaffirms 2025 Full-Year Revenue Guidance of $270-$280 Million, Marking Another Year of Strong Growth

Doubling of VEVYE® Sales Force is On Track, Expansion of IHEEZO® Commercial Footprint to  the Office-Based Setting Underway, and Doubling TRIESENCE® Commercial Footprint in the Surgical-Based Setting is Proceeding OneHarrow Initiative is Launched to Unify Branding...

HROW - Harrow: Revisiting This Eyecare Growth Story Ahead Of Q4 Update

2026-01-22 18:06:16 ET Shares of eyecare specialist Harrow, Inc. ( HROW ) have risen by 219% over the past three years as the company increased its focus on branded products segment and diversified away from its initial compounding business.... Read the full article on Seeking...

HROW - Harrow: Flirting With Missing 2025 Revised Guidance

2026-01-12 12:49:18 ET Read the full article on Seeking Alpha For further details see: Harrow: Flirting With Missing 2025 Revised Guidance

HROW - How My Seeking Alpha Stock Portfolio Crushed S&P 500

2025-12-28 03:25:59 ET Article Thesis The year is coming to an end, and I would like to present the performance of my stock portfolio presented at Seeking Alpha. I started writing at Seeking Alpha in September 2024, so this is a relatively new portfolio.... Read the full artic...

HROW - Undercovered Dozen: USA Rare Earth, Santacruz Silver, Western Midstream, Visa And More

2025-12-08 11:31:49 ET The Undercovered Dozen is a weekly Seeking Alpha editor-curated series highlighting 12 articles on lesser-covered stocks from the previous seven days. We hope this provides ideas and inspires discussion among the community.... Read the full article on Seekin...

Previous 10 Next 10